nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—PGR—Betamethasone—psoriatic arthritis	0.248	0.494	CbGbCtD
Etonogestrel—PGR—Dexamethasone—psoriatic arthritis	0.144	0.287	CbGbCtD
Etonogestrel—Danazol—Prednisone—psoriatic arthritis	0.129	0.33	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisone—psoriatic arthritis	0.092	0.236	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0898	0.23	CrCrCtD
Etonogestrel—Testosterone—Prednisolone—psoriatic arthritis	0.08	0.205	CrCrCtD
Etonogestrel—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0272	0.0542	CbGbCtD
Etonogestrel—CYP3A4—Triamcinolone—psoriatic arthritis	0.0206	0.041	CbGbCtD
Etonogestrel—CYP3A4—Betamethasone—psoriatic arthritis	0.0177	0.0352	CbGbCtD
Etonogestrel—CYP3A4—Prednisolone—psoriatic arthritis	0.0174	0.0347	CbGbCtD
Etonogestrel—CYP3A4—Prednisone—psoriatic arthritis	0.0165	0.0328	CbGbCtD
Etonogestrel—CYP3A4—Dexamethasone—psoriatic arthritis	0.0103	0.0205	CbGbCtD
Etonogestrel—Discomfort—Prednisolone—psoriatic arthritis	0.000185	0.00172	CcSEcCtD
Etonogestrel—Angioedema—Triamcinolone—psoriatic arthritis	0.000185	0.00172	CcSEcCtD
Etonogestrel—Haemoglobin—Prednisone—psoriatic arthritis	0.000184	0.00172	CcSEcCtD
Etonogestrel—Angioedema—Methylprednisolone—psoriatic arthritis	0.000184	0.00172	CcSEcCtD
Etonogestrel—Haemorrhage—Prednisone—psoriatic arthritis	0.000183	0.00171	CcSEcCtD
Etonogestrel—Erythema—Betamethasone—psoriatic arthritis	0.000183	0.00171	CcSEcCtD
Etonogestrel—Erythema—Dexamethasone—psoriatic arthritis	0.000183	0.00171	CcSEcCtD
Etonogestrel—Malaise—Triamcinolone—psoriatic arthritis	0.000182	0.0017	CcSEcCtD
Etonogestrel—Malaise—Methylprednisolone—psoriatic arthritis	0.000182	0.0017	CcSEcCtD
Etonogestrel—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00018	0.00168	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000179	0.00167	CcSEcCtD
Etonogestrel—Oedema—Prednisolone—psoriatic arthritis	0.000179	0.00167	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—psoriatic arthritis	0.000179	0.00167	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000178	0.00166	CcSEcCtD
Etonogestrel—Cough—Triamcinolone—psoriatic arthritis	0.000176	0.00165	CcSEcCtD
Etonogestrel—Convulsion—Triamcinolone—psoriatic arthritis	0.000175	0.00163	CcSEcCtD
Etonogestrel—Convulsion—Methylprednisolone—psoriatic arthritis	0.000175	0.00163	CcSEcCtD
Etonogestrel—Hypertension—Triamcinolone—psoriatic arthritis	0.000174	0.00163	CcSEcCtD
Etonogestrel—Hypertension—Methylprednisolone—psoriatic arthritis	0.000174	0.00162	CcSEcCtD
Etonogestrel—Myalgia—Triamcinolone—psoriatic arthritis	0.000172	0.00161	CcSEcCtD
Etonogestrel—Myalgia—Methylprednisolone—psoriatic arthritis	0.000172	0.0016	CcSEcCtD
Etonogestrel—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000172	0.0016	CcSEcCtD
Etonogestrel—Eye disorder—Prednisone—psoriatic arthritis	0.000171	0.0016	CcSEcCtD
Etonogestrel—Anxiety—Methylprednisolone—psoriatic arthritis	0.000171	0.0016	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—psoriatic arthritis	0.000171	0.00159	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—psoriatic arthritis	0.000171	0.00159	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Etonogestrel—Depression—Methotrexate—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Etonogestrel—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Etonogestrel—Discomfort—Triamcinolone—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Etonogestrel—Discomfort—Methylprednisolone—psoriatic arthritis	0.00017	0.00158	CcSEcCtD
Etonogestrel—Angioedema—Dexamethasone—psoriatic arthritis	0.000167	0.00156	CcSEcCtD
Etonogestrel—Angioedema—Betamethasone—psoriatic arthritis	0.000167	0.00156	CcSEcCtD
Etonogestrel—Angiopathy—Prednisone—psoriatic arthritis	0.000166	0.00155	CcSEcCtD
Etonogestrel—Immune system disorder—Prednisone—psoriatic arthritis	0.000166	0.00155	CcSEcCtD
Etonogestrel—Malaise—Dexamethasone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Etonogestrel—Malaise—Betamethasone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Etonogestrel—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Etonogestrel—Oedema—Triamcinolone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Etonogestrel—Infection—Triamcinolone—psoriatic arthritis	0.000164	0.00153	CcSEcCtD
Etonogestrel—Infection—Methylprednisolone—psoriatic arthritis	0.000163	0.00153	CcSEcCtD
Etonogestrel—Insomnia—Prednisolone—psoriatic arthritis	0.000162	0.00151	CcSEcCtD
Etonogestrel—Alopecia—Prednisone—psoriatic arthritis	0.000162	0.00151	CcSEcCtD
Etonogestrel—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000161	0.00151	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisolone—psoriatic arthritis	0.000161	0.0015	CcSEcCtD
Etonogestrel—Mental disorder—Prednisone—psoriatic arthritis	0.000161	0.0015	CcSEcCtD
Etonogestrel—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00016	0.00149	CcSEcCtD
Etonogestrel—Malnutrition—Prednisone—psoriatic arthritis	0.00016	0.00149	CcSEcCtD
Etonogestrel—Erythema—Prednisone—psoriatic arthritis	0.00016	0.00149	CcSEcCtD
Etonogestrel—Convulsion—Dexamethasone—psoriatic arthritis	0.000159	0.00148	CcSEcCtD
Etonogestrel—Convulsion—Betamethasone—psoriatic arthritis	0.000159	0.00148	CcSEcCtD
Etonogestrel—Hypertension—Betamethasone—psoriatic arthritis	0.000158	0.00148	CcSEcCtD
Etonogestrel—Hypertension—Dexamethasone—psoriatic arthritis	0.000158	0.00148	CcSEcCtD
Etonogestrel—Myalgia—Betamethasone—psoriatic arthritis	0.000156	0.00146	CcSEcCtD
Etonogestrel—Myalgia—Dexamethasone—psoriatic arthritis	0.000156	0.00146	CcSEcCtD
Etonogestrel—Anxiety—Betamethasone—psoriatic arthritis	0.000156	0.00145	CcSEcCtD
Etonogestrel—Anxiety—Dexamethasone—psoriatic arthritis	0.000156	0.00145	CcSEcCtD
Etonogestrel—Discomfort—Betamethasone—psoriatic arthritis	0.000154	0.00144	CcSEcCtD
Etonogestrel—Discomfort—Dexamethasone—psoriatic arthritis	0.000154	0.00144	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—psoriatic arthritis	0.000154	0.00144	CcSEcCtD
Etonogestrel—Pain—Prednisolone—psoriatic arthritis	0.000153	0.00143	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—psoriatic arthritis	0.000153	0.00143	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—psoriatic arthritis	0.000152	0.00142	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000151	0.00141	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Oedema—Dexamethasone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Oedema—Betamethasone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Etonogestrel—Insomnia—Triamcinolone—psoriatic arthritis	0.000149	0.00139	CcSEcCtD
Etonogestrel—Insomnia—Methylprednisolone—psoriatic arthritis	0.000149	0.00139	CcSEcCtD
Etonogestrel—Infection—Dexamethasone—psoriatic arthritis	0.000149	0.00139	CcSEcCtD
Etonogestrel—Infection—Betamethasone—psoriatic arthritis	0.000149	0.00139	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Etonogestrel—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Etonogestrel—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Etonogestrel—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000147	0.00137	CcSEcCtD
Etonogestrel—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000147	0.00137	CcSEcCtD
Etonogestrel—Angioedema—Prednisone—psoriatic arthritis	0.000146	0.00136	CcSEcCtD
Etonogestrel—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000145	0.00135	CcSEcCtD
Etonogestrel—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000145	0.00135	CcSEcCtD
Etonogestrel—Malaise—Prednisone—psoriatic arthritis	0.000144	0.00134	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—psoriatic arthritis	0.000143	0.00134	CcSEcCtD
Etonogestrel—Anorexia—Dexamethasone—psoriatic arthritis	0.000143	0.00133	CcSEcCtD
Etonogestrel—Anorexia—Betamethasone—psoriatic arthritis	0.000143	0.00133	CcSEcCtD
Etonogestrel—Urticaria—Prednisolone—psoriatic arthritis	0.000142	0.00133	CcSEcCtD
Etonogestrel—Fatigue—Triamcinolone—psoriatic arthritis	0.000142	0.00133	CcSEcCtD
Etonogestrel—Fatigue—Methylprednisolone—psoriatic arthritis	0.000142	0.00132	CcSEcCtD
Etonogestrel—Pain—Triamcinolone—psoriatic arthritis	0.000141	0.00132	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—psoriatic arthritis	0.000139	0.0013	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—psoriatic arthritis	0.000138	0.00129	CcSEcCtD
Etonogestrel—Convulsion—Prednisone—psoriatic arthritis	0.000138	0.00129	CcSEcCtD
Etonogestrel—Hypertension—Prednisone—psoriatic arthritis	0.000138	0.00129	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Arthralgia—Prednisone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Myalgia—Prednisone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Etonogestrel—Anxiety—Prednisone—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Insomnia—Dexamethasone—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Insomnia—Betamethasone—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000135	0.00126	CcSEcCtD
Etonogestrel—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Etonogestrel—Paraesthesia—Betamethasone—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Etonogestrel—Discomfort—Prednisone—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—psoriatic arthritis	0.000133	0.00125	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—psoriatic arthritis	0.000133	0.00125	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000132	0.00123	CcSEcCtD
Etonogestrel—Dyspepsia—Betamethasone—psoriatic arthritis	0.000132	0.00123	CcSEcCtD
Etonogestrel—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000132	0.00123	CcSEcCtD
Etonogestrel—Urticaria—Triamcinolone—psoriatic arthritis	0.000131	0.00122	CcSEcCtD
Etonogestrel—Urticaria—Methylprednisolone—psoriatic arthritis	0.000131	0.00122	CcSEcCtD
Etonogestrel—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00013	0.00122	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00013	0.00122	CcSEcCtD
Etonogestrel—Oedema—Prednisone—psoriatic arthritis	0.00013	0.00122	CcSEcCtD
Etonogestrel—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00013	0.00121	CcSEcCtD
Etonogestrel—Decreased appetite—Betamethasone—psoriatic arthritis	0.00013	0.00121	CcSEcCtD
Etonogestrel—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00013	0.00121	CcSEcCtD
Etonogestrel—Infection—Prednisone—psoriatic arthritis	0.000129	0.00121	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000129	0.00121	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000129	0.00121	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Etonogestrel—Fatigue—Dexamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Etonogestrel—Fatigue—Betamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Etonogestrel—Pain—Betamethasone—psoriatic arthritis	0.000128	0.00119	CcSEcCtD
Etonogestrel—Pain—Dexamethasone—psoriatic arthritis	0.000128	0.00119	CcSEcCtD
Etonogestrel—Nervous system disorder—Prednisone—psoriatic arthritis	0.000128	0.00119	CcSEcCtD
Etonogestrel—Skin disorder—Prednisone—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—psoriatic arthritis	0.000124	0.00116	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000124	0.00116	CcSEcCtD
Etonogestrel—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000123	0.00115	CcSEcCtD
Etonogestrel—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000123	0.00115	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000122	0.00114	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000122	0.00114	CcSEcCtD
Etonogestrel—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000121	0.00113	CcSEcCtD
Etonogestrel—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000121	0.00113	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—psoriatic arthritis	0.00012	0.00112	CcSEcCtD
Etonogestrel—Urticaria—Betamethasone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Etonogestrel—Urticaria—Dexamethasone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Etonogestrel—Dizziness—Prednisolone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Etonogestrel—Asthenia—Triamcinolone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Abdominal pain—Betamethasone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Body temperature increased—Betamethasone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Asthenia—Methylprednisolone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Insomnia—Prednisone—psoriatic arthritis	0.000118	0.0011	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisone—psoriatic arthritis	0.000117	0.00109	CcSEcCtD
Etonogestrel—Pruritus—Triamcinolone—psoriatic arthritis	0.000117	0.00109	CcSEcCtD
Etonogestrel—Cough—Methotrexate—psoriatic arthritis	0.000116	0.00109	CcSEcCtD
Etonogestrel—Pruritus—Methylprednisolone—psoriatic arthritis	0.000116	0.00109	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—psoriatic arthritis	0.000116	0.00108	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—psoriatic arthritis	0.000115	0.00107	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—psoriatic arthritis	0.000114	0.00106	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—psoriatic arthritis	0.000114	0.00106	CcSEcCtD
Etonogestrel—Decreased appetite—Prednisone—psoriatic arthritis	0.000113	0.00106	CcSEcCtD
Etonogestrel—Rash—Prednisolone—psoriatic arthritis	0.000113	0.00106	CcSEcCtD
Etonogestrel—Dermatitis—Prednisolone—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Etonogestrel—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—psoriatic arthritis	0.000112	0.00105	CcSEcCtD
Etonogestrel—Headache—Prednisolone—psoriatic arthritis	0.000112	0.00105	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—psoriatic arthritis	0.000112	0.00105	CcSEcCtD
Etonogestrel—Constipation—Prednisone—psoriatic arthritis	0.000111	0.00104	CcSEcCtD
Etonogestrel—Dizziness—Triamcinolone—psoriatic arthritis	0.000109	0.00102	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000109	0.00102	CcSEcCtD
Etonogestrel—Dizziness—Methylprednisolone—psoriatic arthritis	0.000109	0.00102	CcSEcCtD
Etonogestrel—Infection—Methotrexate—psoriatic arthritis	0.000108	0.00101	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisone—psoriatic arthritis	0.000107	0.001	CcSEcCtD
Etonogestrel—Asthenia—Dexamethasone—psoriatic arthritis	0.000107	0.001	CcSEcCtD
Etonogestrel—Asthenia—Betamethasone—psoriatic arthritis	0.000107	0.001	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000107	0.000997	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000107	0.000994	CcSEcCtD
Etonogestrel—Nausea—Prednisolone—psoriatic arthritis	0.000106	0.000994	CcSEcCtD
Etonogestrel—Pruritus—Dexamethasone—psoriatic arthritis	0.000106	0.000988	CcSEcCtD
Etonogestrel—Pruritus—Betamethasone—psoriatic arthritis	0.000106	0.000988	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—psoriatic arthritis	0.000106	0.000987	CcSEcCtD
Etonogestrel—Vomiting—Triamcinolone—psoriatic arthritis	0.000105	0.000978	CcSEcCtD
Etonogestrel—Vomiting—Methylprednisolone—psoriatic arthritis	0.000105	0.000976	CcSEcCtD
Etonogestrel—Rash—Triamcinolone—psoriatic arthritis	0.000104	0.00097	CcSEcCtD
Etonogestrel—Dermatitis—Triamcinolone—psoriatic arthritis	0.000104	0.000969	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—psoriatic arthritis	0.000104	0.000969	CcSEcCtD
Etonogestrel—Rash—Methylprednisolone—psoriatic arthritis	0.000104	0.000968	CcSEcCtD
Etonogestrel—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000104	0.000967	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—psoriatic arthritis	0.000104	0.000966	CcSEcCtD
Etonogestrel—Headache—Triamcinolone—psoriatic arthritis	0.000103	0.000964	CcSEcCtD
Etonogestrel—Headache—Methylprednisolone—psoriatic arthritis	0.000103	0.000962	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—psoriatic arthritis	0.000103	0.000961	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—psoriatic arthritis	0.000103	0.000961	CcSEcCtD
Etonogestrel—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000102	0.000955	CcSEcCtD
Etonogestrel—Diarrhoea—Betamethasone—psoriatic arthritis	0.000102	0.000955	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	9.92e-05	0.000926	CcSEcCtD
Etonogestrel—Dizziness—Dexamethasone—psoriatic arthritis	9.89e-05	0.000923	CcSEcCtD
Etonogestrel—Dizziness—Betamethasone—psoriatic arthritis	9.89e-05	0.000923	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—psoriatic arthritis	9.85e-05	0.000919	CcSEcCtD
Etonogestrel—Nausea—Triamcinolone—psoriatic arthritis	9.79e-05	0.000914	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—psoriatic arthritis	9.78e-05	0.000912	CcSEcCtD
Etonogestrel—Nausea—Methylprednisolone—psoriatic arthritis	9.77e-05	0.000912	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—psoriatic arthritis	9.68e-05	0.000903	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisone—psoriatic arthritis	9.6e-05	0.000896	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—psoriatic arthritis	9.58e-05	0.000894	CcSEcCtD
Etonogestrel—Vomiting—Betamethasone—psoriatic arthritis	9.51e-05	0.000888	CcSEcCtD
Etonogestrel—Vomiting—Dexamethasone—psoriatic arthritis	9.51e-05	0.000888	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—psoriatic arthritis	9.47e-05	0.000883	CcSEcCtD
Etonogestrel—Rash—Betamethasone—psoriatic arthritis	9.43e-05	0.00088	CcSEcCtD
Etonogestrel—Rash—Dexamethasone—psoriatic arthritis	9.43e-05	0.00088	CcSEcCtD
Etonogestrel—Dermatitis—Dexamethasone—psoriatic arthritis	9.42e-05	0.00088	CcSEcCtD
Etonogestrel—Dermatitis—Betamethasone—psoriatic arthritis	9.42e-05	0.00088	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	9.4e-05	0.000877	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—psoriatic arthritis	9.39e-05	0.000876	CcSEcCtD
Etonogestrel—Headache—Dexamethasone—psoriatic arthritis	9.37e-05	0.000875	CcSEcCtD
Etonogestrel—Headache—Betamethasone—psoriatic arthritis	9.37e-05	0.000875	CcSEcCtD
Etonogestrel—Asthenia—Prednisone—psoriatic arthritis	9.35e-05	0.000872	CcSEcCtD
Etonogestrel—Pain—Methotrexate—psoriatic arthritis	9.31e-05	0.000869	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—psoriatic arthritis	9.22e-05	0.00086	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—psoriatic arthritis	8.97e-05	0.000837	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—psoriatic arthritis	8.91e-05	0.000832	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—psoriatic arthritis	8.9e-05	0.000831	CcSEcCtD
Etonogestrel—Nausea—Betamethasone—psoriatic arthritis	8.89e-05	0.000829	CcSEcCtD
Etonogestrel—Nausea—Dexamethasone—psoriatic arthritis	8.89e-05	0.000829	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—psoriatic arthritis	8.65e-05	0.000807	CcSEcCtD
Etonogestrel—Dizziness—Prednisone—psoriatic arthritis	8.62e-05	0.000804	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—psoriatic arthritis	8.61e-05	0.000803	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—psoriatic arthritis	8.61e-05	0.000803	CcSEcCtD
Etonogestrel—Vomiting—Prednisone—psoriatic arthritis	8.28e-05	0.000773	CcSEcCtD
Etonogestrel—Rash—Prednisone—psoriatic arthritis	8.21e-05	0.000767	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—psoriatic arthritis	8.21e-05	0.000766	CcSEcCtD
Etonogestrel—Headache—Prednisone—psoriatic arthritis	8.16e-05	0.000762	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—psoriatic arthritis	8.02e-05	0.000749	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—psoriatic arthritis	7.81e-05	0.000729	CcSEcCtD
Etonogestrel—Nausea—Prednisone—psoriatic arthritis	7.74e-05	0.000722	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—psoriatic arthritis	7.7e-05	0.000719	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—psoriatic arthritis	7.45e-05	0.000695	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—psoriatic arthritis	7.2e-05	0.000672	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—psoriatic arthritis	6.92e-05	0.000646	CcSEcCtD
Etonogestrel—Rash—Methotrexate—psoriatic arthritis	6.87e-05	0.000641	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—psoriatic arthritis	6.86e-05	0.00064	CcSEcCtD
Etonogestrel—Headache—Methotrexate—psoriatic arthritis	6.82e-05	0.000637	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—psoriatic arthritis	6.47e-05	0.000604	CcSEcCtD
